WMSA
CLLS

Weiss Multi-Strategy Advisers’s Cellectis CLLS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-26,300
Closed -$909K – 454
2015
Q1 		$909K Buy
+26,300
New +$954K 0.04% 328

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CLLS Position: Q2 2015 in Review

Weiss Multi-Strategy Advisers sold out of Cellectis (CLLS) in Q2 2015, closing a stake of 26,300 shares — an estimated $909K sold.

Weiss Multi-Strategy Advisers first reported a position in CLLS in Q1 2015 and held it in 1 quarter. The position peaked at $909K in Q1 2015. 40 funds tracked by Wall St. Rank hold CLLS as of Q2 2015.

  • Weiss Multi-Strategy Advisers reported no remaining Cellectis position as of Q2 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 26,300 Cellectis shares in Q2 2015, an estimated $909K.
  • Weiss Multi-Strategy Advisers first reported a position in Cellectis in Q1 2015 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Cellectis position peaked at $909K in Q1 2015.
  • 40 funds tracked by Wall St. Rank held Cellectis as of Q2 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.